CXCL8 and Langerhans cell histiocytosis: (14) identified that serum inflammatory cytokine levels correspond with vemurafenib treatment, and that RAF inhibition leads to a reduction in the expression of cytokines such as IL1B and CXCL8, which are associated with LCH.